# 참고문헌
120. Milewski M, Mastalerz L, Nizankowska E, Szczeklik A. Nasal provocation test with lysine-aspirin for diagnosis of aspirin-sensitive asthma. The Journal of allergy and clinical immunology 1998;101:581-586.
121. Nizankowska E, Bestynska-Krypel A, Cmiel A, Szczeklik A. Oral and bronchial provocation tests with aspirin for diagnosis of aspirin-induced asthma. The European respiratory journal 2000;15:863-869.
122. Szczeklik A, Stevenson DD. Aspirin-induced asthma: advances in pathogenesis and management. The Journal of allergy and clinical immunology 1999;104:5-13.
123. El Miedany Y, Youssef S, Ahmed I, El Gaafary M. Safety of etoricoxib, a specific cyclooxygenase-2 inhibitor, in asthmatic patients with aspirin-exacerbated respiratory disease. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2006;97:105-109.
124. Pleskow WW, Stevenson DD, Mathison DA, Simon RA, Schatz M, Zeiger RS. Aspirin desensitization in aspirin-sensitive asthmatic patients: clinical manifestations and characterization of the refractory period. The Journal of allergy and clinical immunology 1982;69:11-19.
125. Varghese M, Lockey RF. Aspirin-exacerbated asthma. Allergy, Asthma & Clinical Immunology 2008;4:75.
126. Swierczynska-Krepa M, Sanak M, Bochenek G, et al. Aspirin desensitization in patients with aspirin-induced and aspirin-tolerant asthma: a double-blind study. The Journal of allergy and clinical immunology 2014;134:883-890.
127. Woods BD, Sladen RN. Perioperative considerations for the patient with asthma and bronchospasm. Br J Anaesth 2009;103 Suppl 1:i57-i65.
128. Cheney FW, Posner KL, Caplan RA. Adverse respiratory events infrequently leading to malpractice suits. A closed claims analysis. Anesthesiology 1991;75:932-939.
129. Warner DO, Warner MA, Barnes RD, et al. Perioperative respiratory complications in patients with asthma. Anesthesiology 1996;85:460-467.
130. Su FW, Beckman DB, Yarnold PA, Grammer LC. Low incidence of complications in asthmatic patients treated with preoperative corticosteroids. Allergy Asthma Proc 2004;25:327-333.
131. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. 2019. (Accessed 25 Jul 2019.
132. Renew JR, Aniskevich S. Perioperative Pulmonary Medication Management. Current clinical pharmacology 2017;12:182-187.
133. Gluck JC, Gluck PA. The effect of pregnancy on the course of asthma. Immunology and allergy clinics of North America 2006;26:63-80.
134. Murphy VE, Clifton VL, Gibson PG. Asthma exacerbations during pregnancy: incidence and association with adverse pregnancy outcomes. Thorax 2006;61:169-176.
135. Murphy VE, Powell H, Wark PA, Gibson PG. A prospective study of respiratory viral infection in pregnant women with and without asthma. Chest 2013;144:420-427.
136. Murphy VE, Gibson PG. Asthma in pregnancy. Clin Chest Med 2011;32:93-110.
137. Lim A, Stewart K, Konig K, George J. Systematic review of the safety of regular preventive asthma medications during pregnancy. Ann Pharmacother 2011;45:931-945.
138. Wendel PJ, Ramin SM, Barnett-Hamm C, Rowe TF, Cunningham FG. Asthma treatment in pregnancy: a randomized controlled study. American journal of obstetrics and gynecology 1996;175:150-154.
139. Schatz M, Leibman C. Inhaled corticosteroid use and outcomes in pregnancy. Annals of Allergy, Asthma & Immunology 2005;95:234-238.
140. Powell H, Murphy VE, Taylor DR, et al. Management of asthma in pregnancy guided by measurement of fraction of exhaled nitric oxide: a double-blind, randomised controlled trial. Lancet 2011;378:983-990.
141. Hsu J, Chen J, Mirabelli MC. Asthma morbidity, comorbidities, and modifiable factors among older adults. The
<PAGE>157